Mary Dunn, MSN, NP-C, OCN, RN, highlights advances in advanced prostate cancer, including earlier systemic therapy, PSMA-PET, and PARP inhibitors.
Mary Dunn, MSN, NP-C, OCN, RN
Advertisement
Articles by Mary Dunn, MSN, NP-C, OCN, RN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
2
Study shows variability in response to long-term tamsulosin therapy
3
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBC
4
Bringing POTOMAC Data Into Community Urology Practice for High-Risk NMIBC
5